HomeVSTM • NASDAQ
add
Verastem Inc
Previous close
$9.35
Day range
$9.25 - $9.84
Year range
$2.54 - $11.25
Market cap
598.22M USD
Avg Volume
2.84M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.14M | -78.63% |
Operating expense | 45.58M | 61.20% |
Net income | -25.93M | -214.12% |
Net profit margin | -1.21K | -1,369.92% |
Earnings per share | -0.63 | -3.28% |
EBITDA | -43.64M | -138.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 164.32M | 97.10% |
Total assets | 196.26M | 85.60% |
Total liabilities | 160.21M | 143.71% |
Total equity | 36.06M | — |
Shares outstanding | 61.55M | — |
Price to book | 15.85 | — |
Return on assets | -66.72% | — |
Return on capital | -132.51% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -25.93M | -214.12% |
Cash from operations | -32.66M | -18.47% |
Cash from investing | — | — |
Cash from financing | 79.42M | 19,708.89% |
Net change in cash | 46.75M | 4,492.63% |
Free cash flow | -13.17M | 33.84% |
About
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Headquarters
Website
Employees
78
